CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors — Stella

Home/Lung Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Lung Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, Anhui

Key details

Phase

Early testing

Sponsor

Chongqing Precision Biotech Co., Ltd

Enrollment target

~108 participants

Started

September 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.